Inaccuracies in assignment of clinical stage for localized prostate cancer
暂无分享,去创建一个
Matthew R. Cooperberg | Natalia Sadetsky | M. Cooperberg | P. Carroll | Peter R. Carroll | Adam C. Reese | N. Sadetsky | A. Reese
[1] M. Cooperberg,et al. The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry. , 2004, The Journal of urology.
[2] Mao Qi-qi. Anatomic radical retropubic prostatectomy , 2010 .
[3] M. Roobol,et al. The interobserver variability of digital rectal examination in a large randomized trial for the screening of prostate cancer , 2008, The Prostate.
[4] Liang Cheng,et al. Is it necessary to separate clinical stage T1c from T2 prostate adenocarcinoma? , 2005, BJU international.
[5] Z. Hall. Cancer , 1906, The Hospital.
[6] K. Palmer,et al. Predictive factors for positive surgical margins and their locations after robot-assisted laparoscopic radical prostatectomy. , 2010, European urology.
[7] M. Cooperberg,et al. Minimal impact of clinical stage on prostate cancer prognosis among contemporary patients with clinically localized disease. , 2010, The Journal of urology.
[8] M. Lock,et al. Controversies in prostate cancer staging implementation at a tertiary cancer center. , 2006, The Canadian journal of urology.
[9] Daan Brandenbarg. The National. , 1892 .
[10] C. Compton,et al. AJCC Cancer Staging Manual , 2002, Springer New York.
[11] M. Kattan,et al. Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. , 2006, Journal of the National Cancer Institute.
[12] D. Lubeck,et al. The CaPSURE database: a methodology for clinical practice and research in prostate cancer. CaPSURE Research Panel. Cancer of the Prostate Strategic Urologic Research Endeavor. , 1996, Urology.
[13] I. Fleming,et al. The national cancer data base report on recent hospital cancer program progress toward complete American joint committee on cancer/TNM staging , 1997, Cancer.
[14] M. Cooperberg,et al. The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy. , 2005, The Journal of urology.
[15] D. Chan,et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. , 1993, The Journal of urology.
[16] E. Bergstralh,et al. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate‐specific antigen testing: 15‐year outcome , 2005, BJU international.
[17] Anthony V D'Amico,et al. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes. , 2007, The Journal of urology.
[18] M. Cooperberg,et al. Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE). , 2003, The Journal of urology.
[19] Pierre I Karakiewicz,et al. An updated catalog of prostate cancer predictive tools , 2008, Cancer.
[20] P. Carroll,et al. The importance of tumor palpability and transrectal ultrasonographic appearance in the contemporary clinical staging of prostate cancer. , 2011, Urologic oncology.
[21] Athanase Billis,et al. Are prostate carcinoma clinical stages T1c and T2 similar? , 2006, International braz j urol : official journal of the Brazilian Society of Urology.
[22] Srinivasan Vijayakumar,et al. Clinical staging of prostate cancer: Reproducibility and clarification of issues , 2001, International journal of cancer.
[23] A. Partin,et al. Anatomic radical retropubic prostatectomy , 2005 .